AstraZeneca India has appointed Bhavana Agrawal as its new Chief Financial Officer(CFO) from October 1, 2023. Agrawal will be succeeding Rajesh Marwaha, who is retiring from the same position on September 30, 2023. Agrawal has been a strategic finance partner for businesses with consistent performance in maximising revenue, margin, and cash for over two decades. In her last role, she served as the CFO of the Services business at GE Healthcare for Middle East, Africa & Russia, where she was responsible for revenue, costs, cash, planning session and financial closing activities in more than 30 countries. At AstraZeneca India, Agrawal will be responsible for the company’s financial strategy and operations, planning and analysis, and investor relations.
AstraZeneca India Ltd. is a leading biopharmaceutical company that develops and commercializes innovative medicines. Operating in over 100 countries, AstraZeneca has a focus on oncology, respiratory and autoimmune diseases, with operations in the UK, the US and China.
Rajesh Marwaha steps down as the Chief Financial Officer (CFO) and full-time director of AstraZeneca India on September 30, 2023. He has played an instrumental role in building strategic frameworks for the company and has been a strong anchor behind key initiatives focused on improving access to healthcare. A board member and an asset to the company, Marwaha leaves a lasting legacy at AstraZeneca India.
